Deakin University
Browse

Isolating the impact of antipsychotic medication on metabolic health: Secondary analysis of a randomized controlled trial of antipsychotic medication versus placebo in antipsychotic medication naïve first-episode psychosis (the STAGES study)

Version 3 2024-06-19, 15:51
Version 2 2024-06-02, 14:45
Version 1 2023-05-03, 23:58
journal contribution
posted on 2024-06-19, 15:51 authored by B O'Donoghue, K Allott, S Harrigan, F Scalzo, J Ward, S Mallawaarachchi, S Whitson, L Baldwin, J Graham, E Mullen, C MacNeil, D Alexander, SJ Wood, Michael BerkMichael Berk, M Alvarez-Jimenez, A Thompson, A Fornito, HP Yuen, B Nelson, SM Francey, P McGorry
Isolating the impact of antipsychotic medication on metabolic health: Secondary analysis of a randomized controlled trial of antipsychotic medication versus placebo in antipsychotic medication naïve first-episode psychosis (the STAGES study)

History

Journal

Early Intervention in Psychiatry

Volume

17

Pagination

597-607

Location

London, Eng.

Publisher DOI

ISSN

1751-7885

eISSN

1751-7893

Language

eng

Author URL

Publication classification

C1.1 Refereed article in a scholarly journal

Issue

6

Publisher

Wiley

Publication URL

Usage metrics

    Research Publications

    Categories

    Keywords

    antipsychotic medicationLife Sciences & Biomedicinemetabolic syndromeobesityOBESITYPEOPLEPREVALENCEPsychiatrypsychosisRISK-FACTORSschizophreniaSCHIZOPHRENIAScience & Technology

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC